A History of Drug Advertising: The Evolving Roles of Consumers and Consumer Protection
- 10 November 2006
- journal article
- review article
- Published by Wiley in The Milbank Quarterly
- Vol. 84 (4) , 659-699
- https://doi.org/10.1111/j.1468-0009.2006.00464.x
Abstract
Direct-to-consumer advertising (DTCA) of prescription drugs in the United States is controversial. Underlying the debate are disagreements over the role of consumers in medical decision making, the appropriateness of consumers engaging in self-diagnosis, and the ethics of an industry promoting potentially dangerous drugs. Drug advertising and federal policy governing drug advertising have both responded to and reinforced changes in the consumer's role in health care and in the doctor-patient relationship over time. This article discusses the history of DTCA in the context of social movements to secure rights for health care patients and consumers, the modern trend toward consumer-oriented medicine, and the implications of DTCA and consumer-oriented medicine for contemporary health policy debates about improving the health care system.Keywords
This publication has 74 references indexed in Scilit:
- For and against: Direct to consumer advertising is medicalising normal human experience: ForBMJ, 2002
- Direct-to-Consumer Advertising — Strengthening Our Health Care SystemNew England Journal of Medicine, 2002
- Direct-to-Consumer Advertising — Education or Emotion Promotion?New England Journal of Medicine, 2002
- Merchants of Health: Medicine and Consumer Culture in the United States, 1900-1940Journal of American History, 2001
- Americans’ Views On Health Policy: A Fifty-Year Historical PerspectiveHealth Affairs, 2001
- The Benefits of Pharmaceutical PromotionJournal of Pharmaceutical Marketing & Management, 1993
- Direct-to the-Public Advertisement of Prescription DrugsNew England Journal of Medicine, 1988
- Adding Insult to InjuryNew England Journal of Medicine, 1983
- Alleged Direct Promotion of Prescription Drugs to ConsumersNew England Journal of Medicine, 1982
- Compensation for Prescription Drug InjuriesVirginia Law Review, 1973